Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of Potent and Metabolically Stable APJ Ligands with High Therapeutic Potential
Cathleen Juhl, Sylvia Els‐Heindl, Ria Schönauer, et al.
ChemMedChem (2016) Vol. 11, Iss. 21, pp. 2378-2384
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Temporal Expression of Apelin/Apelin Receptor in Ischemic Stroke and its Therapeutic Potential
Yili Wu, Xin Wang, Xuan Zhou, et al.
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 251
Derivatization with fatty acids in peptide and protein drug discovery
Peter Kurtzhals, Søren Østergaard, Erica Nishimura, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 1, pp. 59-80
Closed Access | Times Cited: 75
International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand
Cai Read, Duuamene Nyimanu, Thomas Williams, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 4, pp. 467-502
Open Access | Times Cited: 97
Apelinergic System Structure and Function
Kyungsoo Shin, Calem Kenward, Jan K. Rainey
Comprehensive physiology (2017), pp. 407-450
Open Access | Times Cited: 93
The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders
Éric Marsault, Catherine Llorens‐Cortès, Xavier Iturrioz, et al.
Annals of the New York Academy of Sciences (2019) Vol. 1455, Iss. 1, pp. 12-33
Open Access | Times Cited: 56
The apelin/APJ system as a therapeutic target in metabolic diseases
Isabelle Castan‐Laurell, Bernard Masri, Philippe Valet
Expert Opinion on Therapeutic Targets (2018) Vol. 23, Iss. 3, pp. 215-225
Closed Access | Times Cited: 47
Plasma kallikrein cleaves and inactivates apelin-17: Palmitoyl- and PEG-extended apelin-17 analogs as metabolically stable blood pressure-lowering agents
Conrad Fischer, Tess Lamer, Wang Wang, et al.
European Journal of Medicinal Chemistry (2019) Vol. 166, pp. 119-124
Closed Access | Times Cited: 44
Novel Therapeutics in Glaucoma Management
Claudio Bucolo, Chiara Bianca Maria Platania, Filippo Drago, et al.
Current Neuropharmacology (2018) Vol. 16, Iss. 7, pp. 978-992
Open Access | Times Cited: 44
APJ as Promising Therapeutic Target of Peptide Analogues in Myocardial Infarction- and Hypertension-Induced Heart Failure
Daniela Rossin, Roberto Vanni, Marco Lo Iacono, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1408-1408
Open Access | Times Cited: 11
A Systematic Exploration of Macrocyclization in Apelin-13: Impact on Binding, Signaling, Stability, and Cardiovascular Effects
Kien Trân, Alexandre Murza, Xavier Sainsily, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 6, pp. 2266-2277
Closed Access | Times Cited: 34
Apelin and Vasopressin: The Yin and Yang of Water Balance
Pierre-Emmanuel Girault-Sotias, Romain Gerbier, Adrien Flahault, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 26
Apelin/APJ system: a novel promising target for anti-oxidative stress in stroke
Weilin Xu, Jun Yan, Zachary D. Travis, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Metabolically stable apelin analogs: development and functional role in water balance and cardiovascular function
Pierre Couvineau, Catherine Llorens‐Cortès
Clinical Science (2025) Vol. 139, Iss. 02, pp. 131-149
Closed Access
Role of the Vasopressin/Apelin Balance and Potential Use of Metabolically Stable Apelin Analogs in Water Metabolism Disorders
Adrien Flahault, Pierre Couvineau, Rodrigo Alvear‐Perez, et al.
Frontiers in Endocrinology (2017) Vol. 8
Open Access | Times Cited: 28
Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties
Finbarr O’Harte, Vadivel Parthsarathy, Christopher Hogg, et al.
Biochemical Pharmacology (2017) Vol. 146, pp. 165-173
Open Access | Times Cited: 27
A patent review of apelin receptor (APJR) modulators (2014-2019)
Conrad Fischer
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 4, pp. 251-261
Closed Access | Times Cited: 23
Constraining the Side Chain of C-Terminal Amino Acids in Apelin-13 Greatly Increases Affinity, Modulates Signaling, and Improves the Pharmacokinetic Profile
Kien Trân, Robin Van Den Hauwe, Xavier Sainsily, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 9, pp. 5345-5364
Open Access | Times Cited: 18
Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical Candidate
James A. Johnson, Soong‐Hoon Kim, Jiang Ji, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 6, pp. 3086-3099
Closed Access | Times Cited: 17
Apelinergic system in the kidney: implications for diabetic kidney disease
Tilman Müller, Anastasia Z. Kalea, Alonso Márquez, et al.
Physiological Reports (2018) Vol. 6, Iss. 23, pp. e13939-e13939
Open Access | Times Cited: 20
The emerging role of the apelinergic system in kidney physiology and disease
Peter Janssens, Jean-Paul Decuypere, Bert Bammens, et al.
Nephrology Dialysis Transplantation (2021) Vol. 37, Iss. 12, pp. 2314-2326
Open Access | Times Cited: 15
Metabolically stable apelin-analogues, incorporating cyclohexylalanine and homoarginine, as potent apelin receptor activators
Kleinberg X. Fernandez, Conrad Fischer, Jennie Vu, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 8, pp. 1402-1413
Open Access | Times Cited: 13
Size-Reduced Macrocyclic Analogues of [Pyr1]-apelin-13 Showing Negative Gα12 Bias Still Produce Prolonged Cardiac Effects
Kien Trân, Xavier Sainsily, Jérôme Côté, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 1, pp. 531-551
Closed Access | Times Cited: 10
Apelin/ELABELA-APJ system in cardiac hypertrophy: Regulatory mechanisms and therapeutic potential
Bo Pang, Yin-Ru Jiang, Jia-Yao Xu, et al.
European Journal of Pharmacology (2023) Vol. 949, pp. 175727-175727
Closed Access | Times Cited: 5
Structure–Activity Relationship and Bioactivity of Short Analogues of ELABELA as Agonists of the Apelin Receptor
Kien Trân, Alexandre Murza, Xavier Sainsily, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 602-615
Closed Access | Times Cited: 12
Apelin conformational and binding equilibria upon micelle interaction primarily depend on membrane-mimetic headgroup
Kyungsoo Shin, Muzaddid Sarker, Shuya Kate Huang, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top